StonvexLoading…
StonvexStonvexStonvexCore line items from STT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.80B | $13.94B | $10.28B | $6.73B |
Operating Income | $969.00M | $3.73B | $2.81B | $1.71B |
Net Income | $764.00M | $2.94B | $2.20B | $693.00M |
EPS (Diluted) | $2.49 | $9.40 | $6.98 | $4.21 |
Total Assets | $392.17B | $366.05B | $371.07B | $376.72B |
Total Liabilities | $364.42B | $338.21B | $343.43B | $349.41B |
Cash & Equivalents | $6.52B | $4.43B | $4.76B | $4.02B |
Free Cash Flow OCF − CapEx | $-12.41B | $10.84B | $1.07B | $-6.59B |
Shares Outstanding | 276.92M | 279.08M | 282.22M | 285.56M |